HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of visceral leishmaniasis in Finnish-type congenital nephrotic syndrome.

Abstract
Visceral leishmaniasis is a parasitic disease endemic in the Mediterranean Basin, including Malta. Finnish-type congenital nephrotic syndrome is an autosomal recessive condition that presents in the first 3 months of life with heavy proteinuria, hypoalbuminemia with secondary edema, and hyperlipidemia. We present an infant with congenital nephrotic syndrome who had had unilateral nephrectomy and who also developed visceral leishmaniasis. He was successfully cleared of the infection by the administration of sodium stibogluconate, with no deterioration of renal function or other complications.
AuthorsV Grech, C Vella, R Parascandolo
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 14 Issue 5 Pg. 410-1 (May 2000) ISSN: 0931-041X [Print] Germany
PMID10805470 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiprotozoal Agents
  • Antimony Sodium Gluconate
Topics
  • Antimony Sodium Gluconate (therapeutic use)
  • Antiprotozoal Agents (therapeutic use)
  • Humans
  • Infant
  • Leishmaniasis (complications, drug therapy)
  • Male
  • Nephrotic Syndrome (complications, congenital)
  • Viscera (parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: